Zang L et al. |
The effects of lung and prostate cancer bone metastasis on serum osteoprotegerin levels: a meta-analysis. |
2015 |
Sci Rep |
pmid:26671549
|
Kato G et al. |
The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study. |
2015 |
Arthritis Res. Ther. |
pmid:26373710
|
Li CW et al. |
Opg/Rankl mRNA dynamic expression in the bone tissue of ovariectomized rats with osteoporosis. |
2015 |
Genet. Mol. Res. |
pmid:26345854
|
Pan X et al. |
Association of TRAIL and Its Receptors with Large-Artery Atherosclerotic Stroke. |
2015 |
PLoS ONE |
pmid:26334877
|
Wang B et al. |
Chondrocytes-Specific Expression of Osteoprotegerin Modulates Osteoclast Formation in Metaphyseal Bone. |
2015 |
Sci Rep |
pmid:26329493
|
Fernández-González FJ et al. |
Experimental evidence of pharmacological management of anchorage in Orthodontics: A systematic review. |
2015 |
Dental Press J Orthod |
pmid:26560822
|
Burton LJ et al. |
Muscadine grape skin extract can antagonize Snail-cathepsin L-mediated invasion, migration and osteoclastogenesis in prostate and breast cancer cells. |
2015 |
Carcinogenesis |
pmid:26069256
|
Collins FL et al. |
Death Receptor 3 (TNFRSF25) Increases Mineral Apposition by Osteoblasts and Region Specific New Bone Formation in the Axial Skeleton of Male DBA/1 Mice. |
2015 |
J Immunol Res |
pmid:26065008
|
Zavala-Cerna MG et al. |
Osteoprotegerin Polymorphisms in a Mexican Population with Rheumatoid Arthritis and Generalized Osteoporosis: A Preliminary Report. |
2015 |
J Immunol Res |
pmid:26065000
|
Zheng Y et al. |
Mesenchymal dental pulp cells attenuate dentin resorption in homeostasis. |
2015 |
J. Dent. Res. |
pmid:25762594
|
Tsuruda T |
Osteoprotegerin: osteo-vascular connection. |
2015 |
J. Atheroscler. Thromb. |
pmid:25740050
|
Shah M et al. |
Local origins impart conserved bone type-related differences in human osteoblast behaviour. |
2015 |
Eur Cell Mater |
pmid:25738584
|
Estanislau IM et al. |
Pleiotropic effects of statins on the treatment of chronic periodontitis--a systematic review. |
2015 |
Br J Clin Pharmacol |
pmid:25444240
|
Esteghamati A et al. |
Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes. |
2015 Aug-Sep |
Arch Cardiovasc Dis |
pmid:26184866
|
SaÄŸlam M et al. |
Effect of sumac extract on serum oxidative status, RANKL/OPG system and alveolar bone loss in experimental periodontitis in rats. |
2015 Jan-Feb |
J Appl Oral Sci |
pmid:25760266
|
Sasso GR et al. |
Elevated serum osteoprotegerin levels in women: friend or foe? |
2015 Nov-Dec |
Rev Assoc Med Bras (1992) |
pmid:26841162
|
Calasans-Maia MD et al. |
Cytocompatibility and biocompatibility of nanostructured carbonated hydroxyapatite spheres for bone repair. |
2015 Nov-Dec |
J Appl Oral Sci |
pmid:26814461
|
Jianru YI et al. |
Static compression regulates OPG expression in periodontal ligament cells via the CAMK II pathway. |
2015 Nov-Dec |
J Appl Oral Sci |
pmid:26814456
|
Kose O et al. |
Influences of Fucoxanthin on Alveolar Bone Resorption in Induced Periodontitis in Rat Molars. |
2016 |
Mar Drugs |
pmid:27043583
|
Shah AP et al. |
Effects of Minocycline on Urine Albumin, Interleukin-6, and Osteoprotegerin in Patients with Diabetic Nephropathy: A Randomized Controlled Pilot Trial. |
2016 |
PLoS ONE |
pmid:27019421
|
Dela Cruz A et al. |
Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate. |
2016 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:27006198
|
Lis GJ et al. |
Influence of osteoclasts and osteoprotegerin on the mode of calcific degeneration of aortic valves. |
2016 |
Pol. Arch. Med. Wewn. |
pmid:27003233
|
Tsuruda T et al. |
Angiotensin II Stimulation of Cardiac Hypertrophy and Functional Decompensation in Osteoprotegerin-Deficient Mice. |
2016 |
Hypertension |
pmid:27001297
|
Kats A et al. |
Aminothiazoles inhibit RANKL- and LPS-mediated osteoclastogenesis and PGE2 production in RAW 264.7 cells. |
2016 |
J. Cell. Mol. Med. |
pmid:26987561
|
Moran CS et al. |
Modulation of Kinin B2 Receptor Signaling Controls Aortic Dilatation and Rupture in the Angiotensin II-Infused Apolipoprotein E-Deficient Mouse. |
2016 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:26966276
|
Cong Q et al. |
p38α MAPK Regulates Lineage Commitment and OPG Synthesis of Bone Marrow Stromal Cells to Prevent Bone Loss under Physiological and Pathological Conditions. |
2016 |
Stem Cell Reports |
pmid:26947973
|
Wang C et al. |
Adenovirus-mediated siRNA targeting CXCR2 attenuates titanium particle-induced osteolysis by suppressing osteoclast formation. |
2016 |
Med. Sci. Monit. |
pmid:26939934
|
Lin J et al. |
Increased generation of Foxp3(+) regulatory T cells by manipulating antigen presentation in the thymus. |
2016 |
Nat Commun |
pmid:26923114
|
Li N et al. |
Calycosin attenuates osteoporosis and regulates the expression of OPG/RANKL in ovariectomized rats MAPK signaling. |
2016 |
Pharmazie |
pmid:29441931
|
Yuan SY et al. |
Puerarin prevents bone loss in ovariectomized mice and inhibits osteoclast formation in vitro. |
2016 |
Chin J Nat Med |
pmid:27114313
|
Davaine JM et al. |
Bone Like Arterial Calcification in Femoral Atherosclerotic Lesions: Prevalence and Role of Osteoprotegerin and Pericytes. |
2016 |
Eur J Vasc Endovasc Surg |
pmid:26652270
|
Li J et al. |
Effect of gallium nitrate on the expression of osteoprotegerin and receptor activator of nuclear factor‑κB ligand in osteoblasts in vivo and in vitro. |
2016 |
Mol Med Rep |
pmid:26647856
|
Cervellati C et al. |
Higher Urinary Levels of 8-Hydroxy-2'-deoxyguanosine Are Associated with a Worse RANKL/OPG Ratio in Postmenopausal Women with Osteopenia. |
2016 |
Oxid Med Cell Longev |
pmid:26635910
|
Alam I et al. |
Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice. |
2016 |
Endocrinology |
pmid:26584014
|
Zhao N et al. |
Isolation and Functional Analysis of an Immortalized Murine Cementocyte Cell Line, IDG-CM6. |
2016 |
J. Bone Miner. Res. |
pmid:26274352
|
Liu YD et al. |
Systemic administration of strontium or NBD peptide ameliorates early stage cartilage degradation of mouse mandibular condyles. |
2016 |
Osteoarthr. Cartil. |
pmid:26256766
|
Liu G et al. |
Endoplasmic reticulum stress-mediated inflammatory signaling pathways within the osteolytic periosteum and interface membrane in particle-induced osteolysis. |
2016 |
Cell Tissue Res. |
pmid:26004143
|
Wang S et al. |
Anti-inflammatory and anti-arthritic effects of taraxasterol on adjuvant-induced arthritis in rats. |
2016 |
J Ethnopharmacol |
pmid:27109342
|
Bergamini A et al. |
Expression of the receptor activator of nuclear factor-kB ligand in peripheral blood mononuclear cells in patients with acute Charcot neuroarthropathy. |
2016 |
Int J Med Sci |
pmid:28090190
|
O'Sullivan S et al. |
Tyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFRβ. |
2016 |
PLoS ONE |
pmid:27737004
|
Li M et al. |
Heparan Sulfate Regulates the Structure and Function of Osteoprotegerin in Osteoclastogenesis. |
2016 |
J. Biol. Chem. |
pmid:27697839
|
Shirakawa J and Kulkarni RN |
Novel factors modulating human β-cell proliferation. |
2016 |
Diabetes Obes Metab |
pmid:27615134
|
Xing R et al. |
Interleukin-21 promotes osteoclastogenesis in RAW264.7 cells through the PI3K/AKT signaling pathway independently of RANKL. |
2016 |
Int. J. Mol. Med. |
pmid:27599586
|
Yongdi L et al. |
[Osteoprotegerin/receptor activator of nuclear factor-κB ligand expression in mandibular distraction osteogenesis regulated by parathyroid hormone]. |
2016 |
Hua Xi Kou Qiang Yi Xue Za Zhi |
pmid:27526445
|
Qian H et al. |
FSH aggravates bone loss in ovariectomised rats with experimental periapical periodontitis. |
2016 |
Mol Med Rep |
pmid:27510616
|
Røysland R et al. |
Diagnostic and Prognostic Properties of Osteoprotegerin in Patients with Acute Dyspnoea: Observations from the Akershus Cardiac Examination (ACE) 2 Study. |
2016 |
PLoS ONE |
pmid:27463973
|
Piemontese M et al. |
Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice. |
2016 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:27460899
|
Zhao JJ et al. |
MicroRNA-145 Mediates Steroid-Induced Necrosis of the Femoral Head by Targeting the OPG/RANK/RANKL Signaling Pathway. |
2016 |
PLoS ONE |
pmid:27459539
|
Ugay L et al. |
Role of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand in Bone Loss Related to Advanced Chronic Obstructive Pulmonary Disease. |
2016 |
Chin. Med. J. |
pmid:27411457
|
Pellegrini GG et al. |
Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner. |
2016 |
Nutrients |
pmid:27409635
|